Your browser doesn't support javascript.
loading
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material.
van der Vorm, Lisa N; Hendriks, Jan C M; Laarakkers, Coby M; Klaver, Siem; Armitage, Andrew E; Bamberg, Alison; Geurts-Moespot, Anneke J; Girelli, Domenico; Herkert, Matthias; Itkonen, Outi; Konrad, Robert J; Tomosugi, Naohisa; Westerman, Mark; Bansal, Sukhvinder S; Campostrini, Natascia; Drakesmith, Hal; Fillet, Marianne; Olbina, Gordana; Pasricha, Sant-Rayn; Pitts, Kelly R; Sloan, John H; Tagliaro, Franco; Weykamp, Cas W; Swinkels, Dorine W.
Afiliação
  • van der Vorm LN; Department of Laboratory Medicine and.
  • Hendriks JC; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands;
  • Laarakkers CM; Department of Laboratory Medicine and Hepcidinanalysis.com, Nijmegen, the Netherlands;
  • Klaver S; Department of Laboratory Medicine and.
  • Armitage AE; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, and Blood Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK;
  • Bamberg A; Corgenix Medical Corporation, Broomfield, CO;
  • Geurts-Moespot AJ; Department of Laboratory Medicine and.
  • Girelli D; Department of Medicine, University of Verona, Verona, Italy;
  • Herkert M; DRG Instruments, Marburg, Germany;
  • Itkonen O; Helsinki University Central Hospital, Laboratory Division HUSLAB, Helsinki, Finland;
  • Konrad RJ; Eli Lilly and Company, Indianapolis, IN;
  • Tomosugi N; Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan;
  • Westerman M; Intrinsic LifeSciences, La Jolla, CA;
  • Bansal SS; Institute of Pharmaceutical Sciences, King's College London, London, UK;
  • Campostrini N; Department of Medicine, University of Verona, Verona, Italy;
  • Drakesmith H; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, and Blood Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK;
  • Fillet M; Department of Analytical Pharmaceutical Chemistry, Institute of Pharmacy, University of Liège, Liège, Belgium;
  • Olbina G; Intrinsic LifeSciences, La Jolla, CA;
  • Pasricha SR; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, and Blood Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK;
  • Pitts KR; Corgenix Medical Corporation, Broomfield, CO;
  • Sloan JH; Eli Lilly and Company, Indianapolis, IN;
  • Tagliaro F; Department of Diagnostics and Public Health, University of Verona, Italy;
  • Weykamp CW; Department of Clinical Chemistry, Queen Beatrix Hospital, Winterswijk, the Netherlands.
  • Swinkels DW; Department of Laboratory Medicine and Hepcidinanalysis.com, Nijmegen, the Netherlands; dorine.swinkels@radboudumc.nl.
Clin Chem ; 62(7): 993-1001, 2016 07.
Article em En | MEDLINE | ID: mdl-27173010
ABSTRACT

BACKGROUND:

Absolute plasma hepcidin concentrations measured by various procedures differ substantially, complicating interpretation of results and rendering reference intervals method dependent. We investigated the degree of equivalence achievable by harmonization and the identification of a commutable secondary reference material to accomplish this goal.

METHODS:

We applied technical procedures to achieve harmonization developed by the Consortium for Harmonization of Clinical Laboratory Results. Eleven plasma hepcidin measurement procedures (5 mass spectrometry based and 6 immunochemical based) quantified native individual plasma samples (n = 32) and native plasma pools (n = 8) to assess analytical performance and current and achievable equivalence. In addition, 8 types of candidate reference materials (3 concentrations each, n = 24) were assessed for their suitability, most notably in terms of commutability, to serve as secondary reference material.

RESULTS:

Absolute hepcidin values and reproducibility (intrameasurement procedure CVs 2.9%-8.7%) differed substantially between measurement procedures, but all were linear and correlated well. The current equivalence (intermeasurement procedure CV 28.6%) between the methods was mainly attributable to differences in calibration and could thus be improved by harmonization with a common calibrator. Linear regression analysis and standardized residuals showed that a candidate reference material consisting of native lyophilized plasma with cryolyoprotectant was commutable for all measurement procedures. Mathematically simulated harmonization with this calibrator resulted in a maximum achievable equivalence of 7.7%.

CONCLUSIONS:

The secondary reference material identified in this study has the potential to substantially improve equivalence between hepcidin measurement procedures and contributes to the establishment of a traceability chain that will ultimately allow standardization of hepcidin measurement results.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepcidinas / Serviços de Laboratório Clínico / Cooperação Internacional Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chem Assunto da revista: QUIMICA CLINICA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepcidinas / Serviços de Laboratório Clínico / Cooperação Internacional Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chem Assunto da revista: QUIMICA CLINICA Ano de publicação: 2016 Tipo de documento: Article